Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
暂无分享,去创建一个
A. Jemal | J. Ferlay | F. Bray | R. Siegel | I. Soerjomataram | H. Sung | M. Laversanne
[1] E. Feuer,et al. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials , 2017, Annals of Internal Medicine.
[2] S. Vaccarella,et al. Global trends in thyroid cancer incidence and the impact of overdiagnosis. , 2020, The lancet. Diabetes & endocrinology.
[3] F Levi,et al. European cancer mortality predictions for the year 2019 with focus on breast cancer. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] G. Stevenson,et al. Infection with Helicobacter pylori. , 1996, AJR. American journal of roentgenology.
[5] C. Flowers,et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.
[6] V. Zadnik,et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years , 2019, Gut.
[7] Brian L Sprague,et al. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. , 2014, Epidemiologic reviews.
[8] Alan D. Lopez,et al. Stages of the cigarette epidemic on entering its second century , 2012, Tobacco Control.
[9] V. Beral,et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study , 2007, BMJ : British Medical Journal.
[10] V. McCormack,et al. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. , 2016, The Lancet. Global health.
[11] J. Lortet-Tieulent,et al. Profiling global cancer incidence and mortality by socioeconomic development , 2020, International journal of cancer.
[12] J. Coebergh,et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. , 2012, European journal of cancer.
[13] M. Plummer,et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.
[14] F. Bray,et al. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. , 2016, Salud publica de Mexico.
[15] J. Witte,et al. Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent , 2013, Prostate cancer.
[16] M. Poljak,et al. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. , 2013, Vaccine.
[17] Gretchen L. Gierach,et al. Toward Risk-Stratified Breast Cancer Screening: Considerations for Changes in Screening Guidelines. , 2019, JAMA oncology.
[18] A. Jemal,et al. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. , 2019, The Lancet. Public health.
[19] A. Baccarelli,et al. Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations , 2020, CA: a cancer journal for clinicians.
[20] A. Costello,et al. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate‐specific antigen (PSA) testing on PSA testing in Australia , 2016, BJU international.
[21] S. Temin,et al. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses , 2018, British Medical Journal.
[22] J. Lortet-Tieulent,et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.
[23] Amy Y Chen,et al. Changes in thyroid cancer incidence, post‐2009 American Thyroid Association guidelines , 2017, The Laryngoscope.
[24] A. Jemal,et al. Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.
[25] V. McCormack,et al. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting‐specific exposures to known and putative risk factors , 2017, International journal of cancer.
[26] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.
[27] R. Pfeiffer,et al. Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995–2015) , 2019, Journal of the National Cancer Institute.
[28] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.
[29] A. Omran. The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.
[30] S. Devesa,et al. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 , 2017, JAMA.
[31] J. Ferlay,et al. Cervical cancer burden in Latin America and the Caribbean: Where are we? , 2020, International journal of cancer.
[32] W. Ridtitid,et al. Liver Fluke-Associated Biliary Tract Cancer , 2017, Gut and liver.
[33] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[34] S. Vollmer,et al. Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries. , 2020, JAMA.
[35] R. Sullivan,et al. Screening for Cancer: Considerations for Low- and Middle-Income Countries , 2015 .
[36] H. Welch,et al. South Korea's Thyroid-Cancer "Epidemic"--Turning the Tide. , 2015, The New England journal of medicine.
[37] I. Nagtegaal,et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands , 2020, The Lancet Oncology.
[38] D M Parkin,et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.
[39] R. Udelsman,et al. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. , 2014, Thyroid : official journal of the American Thyroid Association.
[40] P. Sparén,et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. , 2020, The New England journal of medicine.
[41] J. Ferlay,et al. International trends in hepatocellular carcinoma incidence, 1978–2012 , 2020, International journal of cancer.
[42] C. Adebamowo,et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. , 2011, The Lancet. Oncology.
[43] J. Lazarus,et al. Progress towards elimination goals for viral hepatitis , 2020, Nature Reviews Gastroenterology & Hepatology.
[44] P. Pharoah,et al. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model , 2018 .
[45] A. Nations. THE EPIDEMIC. , 1965, Journal of the Medical Association of the State of Alabama.
[46] Gretchen L. Gierach,et al. Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues. , 2017, European journal of cancer.
[47] S. Franceschi,et al. Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese‐Americans between 1985 and 2012 , 2018, International journal of cancer.
[48] N. P. Napalkov,et al. for the prevention and control of noncommunicable diseases , 1999 .
[49] M. Thun,et al. Framework for understanding cancer prevention , 2017 .
[50] E. Ziv,et al. A response to “Personalised medicine and population health: breast and ovarian cancer” , 2019, Human Genetics.
[51] P. Sasieni,et al. Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern? , 2018, Preventive medicine.
[52] Ahmedin Jemal,et al. Global Cancer in Women: Burden and Trends , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[53] J. Lortet-Tieulent,et al. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010. , 2015, European journal of cancer.
[54] Ruth Etzioni,et al. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. , 2018, The Lancet. Global health.
[55] I S Anishchenko,et al. [Stomach cancer]. , 1981, Fel'dsher i akusherka.
[56] F. Bray,et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. , 2007, Journal of the National Cancer Institute.
[57] Megan E O'Brien,et al. Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report , 2017, The Lancet.
[58] P. Vineis,et al. Global cancer patterns: causes and prevention , 2014, The Lancet.
[59] D. Parkin,et al. Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[60] J. Sosa,et al. Influence of nomenclature changes on trends in papillary thyroid cancer incidence in the United States, 2000-2017. , 2020, The Journal of clinical endocrinology and metabolism.
[61] J. Ferlay,et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012 , 2020, Cancer.
[62] Philip S Rosenberg,et al. Incidence of breast cancer in the United States: current and future trends. , 2011, Journal of the National Cancer Institute.
[63] L. Brinton,et al. Global trends in breast cancer incidence and mortality 1973-1997. , 2005, International journal of epidemiology.
[64] Robert N Hoover,et al. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. , 2007, Journal of the National Cancer Institute.
[65] F. Bray,et al. Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12 , 2017, International journal of cancer.
[66] Jacques Ferlay,et al. Cancer in Africa 2012 , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[67] Á. Lanas,et al. Colorectal cancer population screening programs worldwide in 2016: An update , 2017, World journal of gastroenterology.
[68] M. Borok,et al. Trends in cervical cancer incidence in sub-Saharan Africa , 2020, British Journal of Cancer.
[69] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[70] S. Bryan,et al. Cost‐effectiveness of cervical cancer screening methods in low‐ and middle‐income countries: A systematic review , 2017, International journal of cancer.
[71] F. Bray,et al. Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.
[72] Harry J de Koning,et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.
[73] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[74] F. Bray,et al. Global patterns and trends in cancers of the lip, tongue and mouth. , 2020, Oral oncology.
[75] P. Coffey,et al. The International Bank for Reconstruction and Development: The World Bank , 2006 .
[76] M. Babjuk,et al. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. , 2020, European urology.
[77] A. Nessa,et al. Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low‐ and lower‐middle‐income countries , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[78] L. Tanoue,et al. Reduced lung cancer mortality with low-dose computed tomographic screening , 2011 .
[79] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[80] H. Brenner,et al. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer. , 2019, JAMA oncology.
[81] Jacques Ferlay,et al. International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013. , 2018, Journal of the National Cancer Institute.
[82] A. Frille,et al. Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial , 2020, Breathe.
[83] G. Corrao,et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[84] Peter D Siersema,et al. Esophageal cancer. , 2008, Gastroenterology clinics of North America.
[85] Franco Merletti,et al. Cancer transition and priorities for cancer control. , 2012, The Lancet. Oncology.
[86] J. Ferlay,et al. More deaths from pancreatic cancer than breast cancer in the EU by 2017 , 2016, Acta oncologica.
[87] Richard Doll,et al. Cancer incidence in five continents : a technical report , 1966 .
[88] Sidney J. Culture. International Symposium on End Results of Cancer Therapy , 2016 .
[89] E. Wynder,et al. The decline in gastric cancer: epidemiology of an unplanned triumph. , 1986, Epidemiologic reviews.
[90] H. Whittle,et al. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. , 2016, The Lancet. Global health.
[91] Douglas K Owens,et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.
[92] A. Wolk,et al. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis , 2009, International journal of cancer.
[93] F. Bray,et al. A global view on cancer incidence and national levels of the human development index , 2016, International journal of cancer.
[94] Gregory Doyle,et al. Pan-Canadian study of mammography screening and mortality from breast cancer. , 2014, Journal of the National Cancer Institute.
[95] P. Rosenberg,et al. Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark , 2013, International journal of cancer.
[96] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[97] M. García-Closas,et al. Comparative validation of breast cancer risk prediction models and projections for future risk stratification , 2018, bioRxiv.
[98] J. Berk-Krauss,et al. New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986-2016. , 2020, American journal of public health.
[99] M. Blaser,et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. , 2006, Journal of the National Cancer Institute.
[100] B. Graubard,et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare , 2017, PloS one.
[101] A. Gavin,et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. , 2019, The Lancet. Oncology.
[102] A. Jemal,et al. Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries , 2020, International journal of cancer.
[103] E. Bugianesi,et al. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. , 2016, Annual review of medicine.
[104] Michael J Barry,et al. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement , 2017, JAMA.
[105] Jiemin Ma,et al. Response Lehrer and Rheinstein. , 2020, Journal of the National Cancer Institute.
[106] L. Gravitz. Liver cancer , 2014, Nature.
[107] I. Soerjomataram,et al. Breast cancer survival in sub‐Saharan Africa by age, stage at diagnosis and human development index: A population‐based registry study , 2019, International journal of cancer.
[108] P. Glasziou,et al. Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[109] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[110] C. Nickson,et al. Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. , 2011, Vaccine.
[111] F. Bray,et al. The ever‐increasing importance of cancer as a leading cause of premature death worldwide , 2021, Cancer.
[112] V. McCormack,et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. , 2020, The Lancet. Global health.
[113] P. Rosenberg,et al. Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data , 2019, British Journal of Cancer.
[114] R. Millikan,et al. Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006 , 2014, Cancer.
[115] F. Bray,et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries , 2020, The Lancet.
[116] J. Doorbar,et al. Human Papillomaviruses , 2006, Methods in Molecular Medicine.
[117] J. Wilmoth,et al. The Cancer Transition in Japan since 1951 , 2002 .
[118] J. Olsen,et al. Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study , 2007, International journal of cancer.
[119] S. Ng,et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.
[120] F. Bray,et al. Lung cancer incidence trends in Uruguay 1990-2014: An age-period-cohort analysis. , 2018, Cancer epidemiology.
[121] U. Wojciechowska,et al. WHO position paper on mammography screening , 2015 .
[122] M. Lai,et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.
[123] M. Siahpush,et al. Global Inequalities in Cervical Cancer Incidence and Mortality are Linked to Deprivation, Low Socioeconomic Status, and Human Development , 2012, International journal of MCH and AIDS.
[124] F. Bray,et al. Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening , 2005, Cancer Epidemiology Biomarkers & Prevention.
[125] L. G. Koss,et al. Cervical Cancer , 1981, Current Topics in Pathology.
[126] László Tabár,et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening , 2018, Cancer.
[127] D. Forman,et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035 , 2020, Gut.
[128] A. Berg. U.S. Preventive Services Task Force , 2004 .
[129] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[130] Colorectal Cancer Screening in Average-Risk Adults , 2019, Annals of Internal Medicine.
[131] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[132] Prabhat Jha,et al. Avoidable global cancer deaths and total deaths from smoking , 2009, Nature Reviews Cancer.
[133] D. Whiteman,et al. The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031. , 2016, The Journal of investigative dermatology.
[134] Edward L. Giovannucci,et al. Global Burden of 5 Major Types Of Gastrointestinal Cancer. , 2020, Gastroenterology.
[135] C. McConkey,et al. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. , 1990, British Journal of Cancer.
[136] S. Cutler. INTERNATIONAL SYMPOSIUM ON END RESULTS OF CANCER THERAPY. COMPUTATION OF SURVIVAL RATES. , 1964, National Cancer Institute monograph.
[137] J. Sosa,et al. Understanding the ever-changing incidence of thyroid cancer , 2020, Nature Reviews Endocrinology.
[138] Ahmedin Jemal,et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States , 2018, CA: a cancer journal for clinicians.
[139] V. Cogliano. International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.
[140] J. Lortet-Tieulent,et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.
[141] P. Rosenberg,et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults , 2011, Gut.
[142] B. Anderson,et al. Phased implementation for breast cancer management in low‐income and middle‐income countries: A proposal for the strategic application of resource‐stratified guidelines by the Breast Health Global Initiative , 2020, Cancer.
[143] E. Steliarova-Foucher,et al. Global patterns and trends in the incidence of non-Hodgkin lymphoma , 2019, Cancer Causes & Control.
[144] M. Iannacone,et al. Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia. , 2014, Melanoma management.
[145] A. Lok,et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. , 2014, The New England journal of medicine.
[146] M. Cruickshank,et al. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study , 2019, BMJ.
[147] M. Poljak,et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer , 2016, Nature Reviews Clinical Oncology.
[148] A. Jemal,et al. Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening. , 2020, Journal of the National Cancer Institute.
[149] M. S. St John,et al. Epidemiology of Squamous Cell Carcinoma of the Lip in the United States: A Population-Based Cohort Analysis. , 2016, JAMA otolaryngology-- head & neck surgery.
[150] H. Iwase,et al. [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[151] F. Bray,et al. Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries , 2005, Cancer Epidemiology Biomarkers & Prevention.
[152] Kaliszewski,et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .
[153] A. Jemal,et al. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. , 2019, European urology.
[154] D. Rigel. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. , 2008, Journal of the American Academy of Dermatology.
[155] C. Dolea,et al. World Health Organization , 1949, International Organization.
[156] A. Allchin. Emerging , 1978 .
[157] Eugenio Paci,et al. Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review , 2012, Journal of medical screening.
[158] Ahmedin Jemal,et al. Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.
[159] P. Rosenberg,et al. The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites , 2018, Journal of the National Cancer Institute.
[160] H. Ozen. Bladder cancer. , 1998, Current opinion in oncology.
[161] J. Lenzer,et al. Why cancer screening has never been shown to “save lives”—and what we can do about it , 2016, BMJ : British Medical Journal.
[162] Victor M Montori,et al. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours , 2013, BMJ.
[163] P DESAIVE,et al. [Thyroid cancer]. , 1951, Revue medicale de Liege.
[164] David A Jaffray,et al. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition , 2016, The Lancet.
[165] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[166] S. Narod. Personalised medicine and population health: breast and ovarian cancer , 2018, Human Genetics.
[167] A. Jemal,et al. Global patterns and trends in colorectal cancer incidence in young adults , 2019, Gut.
[168] E. Giovannucci,et al. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies , 2019, Nature Reviews Gastroenterology & Hepatology.
[169] E. Lee,et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016 , 2019, Cancer research and treatment : official journal of Korean Cancer Association.
[170] J. Ferlay,et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. , 2019, The lancet. Gastroenterology & hepatology.
[171] R. Peeling,et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. , 2019, The lancet. Gastroenterology & hepatology.
[172] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[173] Ahmedin Jemal,et al. Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[174] R. Greenlee,et al. Cancer Screening during COVID-19: A Perspective from NCI’s PROSPR consortium , 2020, Gastroenterology.
[175] M. Donnelly,et al. Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews , 2020, BMC Cancer.
[176] F. Bray,et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries , 2020, The Lancet.
[177] C. Flowers,et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society , 2020, CA: a cancer journal for clinicians.
[178] J. Fraumeni,et al. Declining lung cancer rates among young men and women in the United States: a cohort analysis. , 1989, Journal of the National Cancer Institute.
[179] Mohsen Beheshti,et al. Chapter 3 – Breast Cancer , 2018 .
[180] C R Key,et al. Biologic characteristics of interval and screen-detected breast cancers. , 2000, Journal of the National Cancer Institute.
[181] J. Lortet-Tieulent,et al. Thyroid cancer “epidemic” also occurs in low‐ and middle‐income countries , 2018, International journal of cancer.
[182] E. Kuipers,et al. Colorectal cancer screening: a global overview of existing programmes , 2015, Gut.
[183] D. Valencia. Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2 , 2020, Cureus.
[184] M. Plummer,et al. Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.
[185] 立道 昌幸. International Agency of Research on Cancer 国際癌研究機構(IARC)留学記 , 2003 .
[186] A. D'Amico,et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.
[187] A. Purushotham,et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study , 2020, The Lancet Oncology.
[188] A. Lastovica,et al. Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? , 1999, Gut.
[189] K. Jørgensen. [Cervix cancer screening]. , 2008, Ugeskrift for laeger.
[190] V. McCormack,et al. Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. , 2020, The Lancet. Global health.
[191] A. Jemal,et al. International variation in prostate cancer incidence and mortality rates. , 2012, European urology.
[192] J. Sung,et al. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. , 2016, European urology.
[193] G. Guyatt,et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline , 2018, British Medical Journal.
[194] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[195] D. Altman,et al. The benefits and harms of breast cancer screening: an independent review , 2012, British Journal of Cancer.
[196] S. Franceschi,et al. Thyroid cancer incidence in India between 2006 and 2014 and impact of overdiagnosis. , 2020, The Journal of clinical endocrinology and metabolism.
[197] Jasmin A. Tiro,et al. Cost-effectiveness studies of HPV self-sampling: A systematic review. , 2020, Preventive medicine.
[198] J. Ferlay,et al. Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends , 2017, International journal of cancer.
[199] C. la Vecchia,et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis , 2014, British Journal of Cancer.
[200] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[201] Jacques Ferlay,et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.
[202] D. Parkin,et al. The global burden of urinary bladder cancer , 2008, Scandinavian journal of urology and nephrology. Supplementum.
[203] N. Sharpless. COVID-19 and cancer , 2020, Science.
[204] F. Bray,et al. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030 , 2017, The American Journal of Gastroenterology.
[205] Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme , 2016, Journal of medical screening.
[206] Michael R Hamblin,et al. CA : A Cancer Journal for Clinicians , 2011 .
[207] F. Callea,et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy , 2001, Cancer Causes & Control.
[208] F. Bray,et al. The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.
[209] A. Jemal,et al. Long-Term Realism and Cost-Effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide , 2015, Journal of the National Cancer Institute.
[210] Clare Gilham,et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials , 2014, The Lancet.
[211] Ahmedin Jemal,et al. Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008 , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[212] P. Easterbrook,et al. Hepatitis C: global epidemiology and strategies for control. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[213] A. Jemal,et al. Emerging cancer incidence trends in Canada: The growing burden of young adult cancers , 2020, Cancer.
[214] S. Narod,et al. Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[215] A. Jemal,et al. Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group , 2016, International journal of cancer.
[216] Dante diTommaso,et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline , 2008, Cancer Causes & Control.
[217] R. Fisher,et al. A War on Two Fronts: Cancer Care in the Time of COVID-19 , 2020, Annals of Internal Medicine.
[218] A. Jemal,et al. Colorectal cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[219] A. Jemal,et al. Higher Lung Cancer Incidence in Young Women Than Young Men in the United States , 2018, The New England journal of medicine.
[220] P. Porter,et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. , 1999, Journal of the National Cancer Institute.
[221] Bey P Le. [Cancer in Africa]. , 2013, Bulletin du cancer.
[222] R. Carlson,et al. The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource‐Stratified Phased Implementation: Methods and overview , 2020, Cancer.
[223] J. Larkin,et al. Current and emerging systemic therapies for cutaneous metastatic melanoma , 2019, Expert opinion on pharmacotherapy.
[224] C. Abnet,et al. The Gastric Cardia Is Not a Target for Human Papillomavirus–Induced Carcinogenesis , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[225] A. Jemal,et al. The evolving epidemic of breast cancer in sub‐Saharan Africa: Results from the African Cancer Registry Network , 2020, International journal of cancer.
[226] M. Babjuk,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. , 2013, European urology.
[227] P. Hartge,et al. The Epidemic of Non–Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992–2009 , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[228] Melissa Matz,et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.
[229] A. Auvinen,et al. Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC. , 2018, The Lancet. Oncology.
[230] Jianping Shi,et al. Indoor air pollution and risk of lung cancer among Chinese female non-smokers , 2013, Cancer Causes & Control.
[231] J. Berkhof,et al. Disease burden of human papillomavirus infection in the Netherlands, 1989–2014: the gap between females and males is diminishing , 2017, Cancer Causes & Control.